Previous 10 | Next 10 |
Strata Skin Sciences ( NASDAQ: SSKN ) on Monday announced the U.S. commercial launch of its acne treatment TheraClear X. Shares of the company soared ~18% after hours to $1.39. The company said the TheraClearX Acne Therapy System is engineered and indicated spe...
HORSHAM, Pa., July 25, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the U.S. commercial launch of Ther...
HORSHAM, Pa., June 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in t...
HORSHAM, Pa., May 16, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Michael E. Goodman has been na...
The following slide deck was published by STRATA Skin Sciences, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: STRATA Skin Sciences, Inc. 2022 Q1 - Results - Earnings Call Presentation
STRATA Skin Sciences, Inc. (SSKN) Q1 2022 Earnings Conference Call May 11, 2022 04:30 PM ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Christopher Lesovitz - Chief Financial Officer Conference Call Participants Destiny Alexandra Buch - Ladenb...
STRATA Skin Sciences press release (NASDAQ:SSKN): Q1 GAAP EPS of -$0.07. Revenue of $7M (+20.1% Y/Y). FY22 revenue expected to be in the range of $33.0M to $35.0M. For further details see: STRATA Skin Sciences GAAP EPS of -$0.07, revenue of $7M
HORSHAM, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the first qua...
HORSHAM, Pa., April 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its firs...
HORSHAM, Pa., March 30, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of various autoimmune skin diseases, today announced that it has become...
News, Short Squeeze, Breakout and More Instantly...
Strata Skin Sciences Inc. Company Name:
SSKN Stock Symbol:
NASDAQ Market:
Strata Skin Sciences Inc. Website:
HORSHAM, Pa., July 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions,...
HORSHAM, Penn., July 22, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic condition...
Study published in Journal of Cosmetic and Laser Therapy highlights the TheraClear ® X photopneumatic device as an effective treatment option, either as monotherapy or in combination with topical or oral treatments, for patients with mild-moderate acne HORSHAM, Pa., J...